Suscribirse

Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping - 26/01/20

Doi : 10.1016/j.diii.2019.08.006 
E. Deborde a, b, , B. Dubourg a, c, d, S. Bejar a, A.-C. Brehin e, S. Normant a, P. Michelin a, J.-N. Dacher a, c, d
a Department of Radiology, University Hospital of Rouen, 76031 Rouen, France 
b Department of Radiology, University Hospital of Strasbourg, 67098 Strasbourg, France 
c INSERM U1096, UFR Médecine Pharmacie, 76183 Rouen, France 
d Institute for Research and Innovation in Biomedicine, University of Rouen, 76000 Rouen, France 
e Department of Genetics, University Hospital of Rouen, 76031 Rouen, France 

Corresponding author. Department of Medical Imaging, University Hospital of Strasbourg, 10, avenue Molière, 67098 Strasbourg, France.Department of Medical Imaging, University Hospital of Strasbourg10, avenue MolièreStrasbourg67098France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Purpose

To evaluate the potential of non-contrast myocardial T1 mapping on cardiovascular magnetic resonance examination (CMR) in differentiating patients with Fabry disease (FD) from those with hypertrophic cardiomyopathy (HCM) and healthy control subjects.

Materials and methods

Seventeen patients with FD (8 men, 9 women; mean age, 48 ±18 [SD] years; [range: 19–73 years]; 53% with left ventricular hypertrophy [LVH]) were matched with 36 patients with hypertrophic cardiomyopathy (HCM) (22 men, 14 women; mean age, 57±16 [SD] years; [range: 22–85 years]) and 70 healthy control subjects (34 men, 36 women; mean age, 38 ±15 [SD] years; [range: 18–65 years]). Cardiac T1 mapping was performed using the modified Look-Locker inversion (MOLLI®) sequence on a 1.5-T magnet. T1 values were calculated, on midventricular section, for septal left ventricular segments (S8–S9) and all mid-ventricular ones (global T1 values; S7–S12). Statistical analysis included unpaired Mann-Whitney test, receiver operating characteristic curve and likelihood ratios.

Results

Septal native T1 values were significantly decreased in patients with FD (889±61 [SD] ms; range: 784–980ms) compared to those with HCM (995±48 [SD] ms; range: 935–1125ms) (P<0.001) and versus healthy controls (965±29 [SD] ms; range: 910–1028ms) (P<0.001). Global native T1 values were also significantly decreased in patients with FD (891±49 [SD] ms; range 794–970ms) compared to those with HCM (995±34 [SD] ms; range: 952–1086ms) (P<0.001) and versus healthy controls (966±27 [SD] ms; range: 920–1042ms) (P<0.001). A septal left ventricular native T1 cutoff value of 940ms could distinguish FD from HCM with 88% sensitivity (95% CI: 73–100%) and 92% specificity (95% CI: 83–100%). Positive likelihood ratio was 11, negative likelihood ratio was 0.12. Compared to controls, the same threshold could distinguish FD with 88% sensitivity (95% CI: 73–100%) and 86% specificity (95% CI: 78–94%). Positive likelihood ratio was 6.3, negative likelihood ratio was 0.14. T1 value was abnormal in 4 of 8 (50%) of FD patients who did not have LVH.

Conclusion

Native T1 values are significantly lower in patients with FD by comparison with those with HCM and healthy volunteers.

El texto completo de este artículo está disponible en PDF.

Keywords : Cardiac magnetic resonance imaging (MRI), Fabry disease, Left ventricular hypertrophy, Hypertrophic cardiomyopathy

Abbreviations : FD, LVH, ERT, CMR, LVM, LGE, LV, MRI, HCM, CI, SD


Esquema


© 2019  Société française de radiologie. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 101 - N° 2

P. 59-67 - février 2020 Regresar al número
Artículo precedente Artículo precedente
  • Editorial board / Ours rédaction
| Artículo siguiente Artículo siguiente
  • Feasibility of two-dimensional ultrasound shear wave elastography of human fetal lungs and liver: A pilot study
  • N. Mottet, C. Cochet, C. Vidal, J.P. Metz, S. Aubry, A. Bourtembourg, A. Eckman-Lacroix, D. Riethmuller, L. Pazart, R. Ramanah

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.